AGIO

Agios Pharmaceuticals
$36.97
+$0.61 (+1.68%)Jul 27, 2026
2.9FairMoatMint rating

MoatMint rates Agios Pharmaceuticals (AGIO) 2.9 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.8 out of 10.

Key metrics

The numbers that frame AGIO today
Market cap
$2.20B
P/E (TTM)
-5.2
EV / FCF
-5.5
Gross margin
90%
EV / Sales
32.1
ROIC
-35%
Div yield
0%
Debt / equity
0.0
52wk Low
$22.24
52wk High
$46.00

AGIO stock rating

How AGIO scores on quality, value, growth, momentum and financial health
2.9out of 10
Fair overallFair business, expensive priceTop 71% of ~5,000 US stocks
QualityFair2.8/10
GrowthNeutral4.2/10
MomentumGood6.7/10
ValuePoor1.5/10
Financial HealthFair3.8/10

Growth

Revenue and earnings trend for AGIO
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about AGIO
Is Agios Pharmaceuticals a good buy?
Hold. Agios Pharmaceuticals has strong momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Agios Pharmaceuticals is selling at a very high price.
What is the market capitalization of AGIO?
Agios Pharmaceuticals's market capitalization is $2.20B.
What is the P/E ratio for AGIO stock?
Agios Pharmaceuticals's current P/E ratio is -5.2.
What is the 52-week high for AGIO stock?
The 52-week high for Agios Pharmaceuticals is $46.00. The current close of $36.97 is 19.6% below that high.
What is the 52-week low for AGIO stock?
The 52-week low for Agios Pharmaceuticals is $22.24. The current close of $36.97 is 66.2% above that low.
Does AGIO stock pay dividends?
Agios Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AGIO?
Agios Pharmaceuticals's Debt / Equity ratio is 0.03.